Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Upgrades Absci to Outperform

Cowen & Co. analyst Steven Mah upgrades Absci (NASDAQ:ABSI) from Market Perform to Outperform.

byBenzinga Newsdesk

August 12, 2022

1 minute read

Cowen & Co. analyst Steven Mah upgrades Absci (NASDAQ:ABSI) from Market Perform to Outperform.

Why Dogecoin Looks Ready To Roam Free From This Bullish Pattern: A Technical Analysis

By Melanie Schaffer

Today, 2:54 PM

Dogecoin (CRYPTO: DOGE) broke up bullishly on Sunday from a descending triangle pattern Benzinga called out two days prior.

$DOGE

Analyzing TSM’s Q3 Revenue: Bloomberg

By Anusuya Lahiri

Today, 2:54 PM

Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM) reported third-quarter FY21 revenue of NT$414.7 billion ($14.8 billion). The September sales rose 20% Y/Y to NT$152.7…

AAPL

Morgan Stanley Upgrades Esperion Therapeutics to Equal-Weight, Announces $9 Price Target

By Benzinga Newsdesk

Today, 2:54 PM

Morgan Stanley analyst Jeffrey Hung upgrades Esperion Therapeutics (NASDAQ:ESPR) from Underweight to Equal-Weight and announces $9 price target.

ESPR

Chart Industries Raises Funds Via Equity & Debt Offerings To Fund Howden Deal

By Shivani Kumaresan

Today, 2:54 PM

Chart Industries Inc (NYSE:GTLS) has priced its previously announced concurrent offering of 5.9 million shares at a public offering price of…

GTLS

Cowen & Co. Upgrades Absci to Outperform

Related Posts

Why Dogecoin Looks Ready To Roam Free From This Bullish Pattern: A Technical Analysis

Analyzing TSM’s Q3 Revenue: Bloomberg

Morgan Stanley Upgrades Esperion Therapeutics to Equal-Weight, Announces $9 Price Target

Chart Industries Raises Funds Via Equity & Debt Offerings To Fund Howden Deal